Cite
HARVARD Citation
Jordan, E. et al. (2021). Broad Antibody and Cellular Immune Response From a Phase 2 Clinical Trial With a Novel Multivalent Poxvirus-Based Respiratory Syncytial Virus Vaccine. Journal of infectious diseases. pp. 1062-1072. [Online].